|
1
|
Witkowski L, Cywinska A, Paschalis-Trela
K, Crisman M and Kita J: Multiple etiologies of equine recurrent
uveitis - A natural model for human autoimmune uveitis: A brief
review. Comp Immunol Microbiol Infect Dis. 44:14–20. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wakefield D and Abi-Hanna D: HLA antigens
and their significance in the pathogenesis of anterior uveitis: A
mini review. Curr Eye Res. 5:465–473. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maca SM, Amirian A, Prause C, Gruber K,
Mejdoubi L and Barisani-Asenbauer T: Understanding the impact of
uveitis on health-related quality of life in adolescents. Acta
Ophthalmol. 91:e219–e224. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Berthet F, Le Deist F, Duliege AM,
Griscelli C and Fischer A: Clinical consequences and treatment of
primary immunodeficiency syndromes characterized by functional T
and B lymphocyte anomalies (combined immune deficiency).
Pediatrics. 93:265–270. 1994.PubMed/NCBI
|
|
5
|
Zhang Q, Lu J, Liang X and Zhi L: The
level and clinical significance of serum IL-17 in patients with
systemic lupus erythematosus. Xibao Yu Fenzi Mianyixue Zazhi.
28:301–303. 2012.In Chinese.
|
|
6
|
Cui Y, Wang G, Li Y, Wang Y, Wang X and Bi
H: Optical coherence tomography and histopathology of macular
uveitis. Optom Vis Sci. 91:1335–1342. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Oh-i K, Keino H, Goto H, Yamakawa N,
Murase K, Usui Y, Kezuka T, Sakai J, Takeuchi M and Usui M:
Intravitreal injection of Tacrolimus (FK506) suppresses ongoing
experimental autoimmune uveoretinitis in Rats. Br J Ophthalmol.
91:237–242. 2007. View Article : Google Scholar
|
|
8
|
Kohno H, Sakai T, Saito S, Okano K and
Kitahara K: Treatment of experimental autoimmune uveoretinitis with
atorvastatin and lovastatin. Exp Eye Res. 84:569–576. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kezic JM, Glant TT, Rosenbaum JT and
Rosenzweig HL: Neutralization of IL-17 ameliorates uveitis but
damages photo-receptors in a murine model of spondyloarthritis.
Arthritis Res Ther. 14:R182012. View
Article : Google Scholar
|
|
10
|
Chi W, Zhu X, Yang P, Liu X, Lin X, Zhou
H, Huang X and Kijlstra A: Upregulated IL-23 and IL-17 in Behçet
patients with active uveitis. Invest Ophthalmol Vis Sci.
49:3058–3064. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sng CC, Ang M and Barton K: Uveitis and
glaucoma: New insights in the pathogenesis and treatment. Prog
Brain Res. 221:243–269. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wells JM and Smith JR: Uveitis in juvenile
idiopathic arthritis: Recent therapeutic advances. Ophthalmic Res.
54:124–127. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zou ZP, Qiang FY, Zhang T, Sun L, Jia T,
Zhu XC and Xu H: Treatment of experimental autoimmune uveitis in
rats with arsenic trioxide. Chin Ophthalmic Res. 28:306–310.
2010.
|
|
14
|
Klímová A, Seidler Štanogová P,
Heissigerová J, Svozílková P and Kučera T: Mycophenolate mofetil
and cyclophosphamide treatments suppress inflammation intensity in
an experimental model of autoimmune uveitis. Folia Biol (Praha).
60:228–234. 2014.
|
|
15
|
Tang Y and Cai L: Research progress of
regulatory T cells and uveitis. Int J Ophthalmol. 11:450–452.
2011.
|
|
16
|
Li J, Chen X, Liu Z, Yue Q and Liu H:
Expression of Th17 cytokines in skin lesions of patients with
psoriasis. J Huazhong Univ Sci Technolog Med Sci. 27:330–332. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
de Smet MD, Taylor SRJ, Bodaghi B,
Miserocchi E, Murray PI, Pleyer U, Zierhut M, Barisani-Asenbauer T,
LeHoang P and Lightman S: Understanding uveitis: The impact of
research on visual outcomes. Prog Retin Eye Res. 30:452–470. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mira A, Tanaka A, Tateyama Y, Kondo R and
Shimizu K: Comparative biological study of roots, stems, leaves,
and seeds of Angelica shikokiana Makino. J Ethnopharmacol.
148:980–987. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Byun MW: Schizonepeta tenuifolia ethanol
extract exerts anti-inflammatory activity through the inhibition of
TLR4 signaling in lipopolysaccharide-stimulated macrophage cells. J
Med Food. 17:350–356. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jäger A and Kuchroo VK: Effector and
regulatory T-cell subsets in autoimmunity and tissue inflammation.
Scand J Immunol. 72:173–184. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tang K, Si J-K, Guo D-D, Cui Y, Du YX, Pan
XM and Bi HS: Ranibizumab alone or in combination with photodynamic
therapy vs photodynamic therapy for polypoidal choroidal
vasculopathy: A systematic review and Meta-analysis. Int J
Ophthalmol. 8:1056–1066. 2015.PubMed/NCBI
|
